primidone Tablets 250 mg

Dossier type
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
Manufacturer #8103
A pharmaceutical manufacturer based in Europe that has been active in Europe and Asia for 80+ years. The main therapeutic areas include CNS and respiratory. Key production lines are Rx, medical devices, and cosmetics. The company's production lines are GMP-compliant.

Manufacturer usually replies in 50 days

Primidone is a medication used to treat epilepsy and seizures. Suppliers of primidone market it as 50mg, 125mg, and 250mg oral tablets, as well as 250mg/5ml suspensions. The drug has been in use for over 70 years and is widely available across most geographic markets. The developer and earliest manufacturer of primidone was AstraZeneca. Today, over 2 million prescriptions of the drug are registered yearly in the U.S., although there, as across other developed markets, second-generation and third-generation anticonvulsant medications are also available. Examples of such substitutes include phenobarbital, carbamazepine, valproate, ethosuximide, primidone, carbamazepine, levetiracetam, brivaracetam, and perampanel. Primidone is widely used in developing countries, and the demand for it, as well as other anticonvulsant drugs, is projected to increase over the near term. Primidone suppliers and distributors market both generic and trade name formulations of the drug. Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified primidone manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform. The cost of 100 (250mg) primidone tablets is approximately 15 EUR.